Home
About
Overview
Sharing Data
ORCID
Help
History (4)
A cluster randomized controlled trial of an adapted U.S. model of pharmaceutical care for nursing home residents in Northern Ireland (Fleetwood Northern Ireland study): a cost-effectiveness analysis.
Frontiers in nephrology: heterologous immunity, T cell cross-reactivity, and alloreactivity.
Genetic Research
In vitro evidence that commercial influenza vaccines are not similar in their ability to activate human T cell responses.
See All 4 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Frontiers in nephrology: heterologous immunity, T cell cross-reactivity, and alloreactivity.
Selin LK, Brehm MA. Frontiers in nephrology: heterologous immunity, T cell cross-reactivity, and alloreactivity. J Am Soc Nephrol. 2007 Aug; 18(8):2268-77.
View in:
PubMed
subject areas
Animals
Antigens, Viral
Cross Reactions
Humans
Isoantigens
Kidney Diseases
Nephrology
T-Lymphocytes
Virus Diseases
authors with profiles
Michael A Brehm PhD
Liisa K Selin MD, PhD